Company intelligence / Profile preview
Palisades Therapeutics
Cliffside Park, New Jersey, United Statespoptestllc.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
FDA clearance to begin Phase II/III COVID-outpatient oral therapeutic study; clinical stage drug PT150 granted patent for Parkinson's Disease and Multiple Sclerosis; breakthrough in addiction treatment with recent patent (April 2025)
- Therapeutic areas
- OncologyOtherPsychiatryNeurologyInfectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Department of DefenseVeterans AdministrationNational Institutes of Health/National Institute of Allergy and Infectious DiseasesNational Cancer InstituteVeterans Medical Research FoundationCDCFDA
Beyond the preview
Go deeper on Palisades Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Palisades Therapeutics.